Esken Limited Stocks

£ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

£ 953167.012

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
£ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Esken Limited operates in the aviation and renewables businesses in the United Kingdom, Europe, and internationally. It operates through Aviation, Renewables, Investments, and Non-Strategic Infrastructure segments. The Aviation segment engages in the operation of commercial airports and the provision of ground handling services. The Renewables segment is involved in the supply of sustainable biomass for the generation of renewable energy. The Investments segment engages in the logistics services investing, and baggage handling businesses. The Non-Strategic Infrastructure segment is involved in the management, development, and realization of a portfolio of property assets, including Carlisle Lake District Airport. The company was formerly known as Stobart Group Limited and changed its name to Esken Limited in February 2021. Esken Limited was incorporated in 2002 and is based in Saint Peter Port, Guernsey.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks